Dana S. Thompson

发表

A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors

Suzanne F. Jones, J. Bendell, H. Burris, 2015, Investigational new drugs.

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute

J. Hainsworth, W. Merritt, V. Gian, 2014, Cancer medicine.

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.

J. Hainsworth, D. Spigel, F. Greco, 2009, The oncologist.

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.

J. Hainsworth, H. Burris, D. Spigel, 2012, Lung cancer.

Phase 1 Results From a Study of Romidepsin in Combination With Gemcitabine in Patients With Advanced Solid Tumors

Suzanne F. Jones, H. Burris, J. Infante, 2012, Cancer investigation.

A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors.

Suzanne F. Jones, J. Bendell, H. Burris, 2011, Clinical advances in hematology & oncology : H&O.

A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle

Suzanne F. Jones, J. Bendell, H. Burris, 2016, Cancer Chemotherapy and Pharmacology.

A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors

Suzanne F. Jones, J. Bendell, H. Burris, 2012, Cancer Chemotherapy and Pharmacology.

Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.

J. Hainsworth, D. Spigel, F. Greco, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors

J. Bendell, H. Burris, D. Spigel, 2016, Cancer investigation.

Paclitaxel/Carboplatin/Etoposide Versus Gemcitabine/Irinotecan in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site: A Randomized, Phase III Sarah Cannon Oncology Research Consortium Trial

J. Hainsworth, D. Spigel, F. Greco, 2010, Cancer journal.

Fludarabine, Rituximab, and Lenalidomide in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): A Phase I/II Trial of the Sarah Cannon Research Institute

J. Reeves, I. Flinn, J. Hainsworth, 2012 .

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma

I. Flinn, S. Papish, R. Boccia, 2018, British journal of haematology.

A phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignancies.

Suzanne F. Jones, H. Burris, J. Infante, 2010, The Oncologist.

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma

J. Hainsworth, H. Burris, J. Infante, 2010, Cancer.

A Phase II Study of the c-Met Inhibitor Tivantinib in Combination with FOLFOX for the Treatment of Patients with Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction, or Stomach

J. Bendell, C. Kurkjian, S. Pant, 2017, Cancer investigation.

Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.

J. Reeves, I. Flinn, J. Hainsworth, 2014, Clinical lymphoma, myeloma & leukemia.

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma

J. Hainsworth, H. Burris, F. Greco, 2002, Cancer.

Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.

J. Hainsworth, H. Burris, D. Yardley, 2007, Clinical lung cancer.

Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial.

J. Hainsworth, M. Stagg, J. B. Erland, 2003, Clinical lung cancer.

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

M. Rubin, J. Hainsworth, H. Burris, 2010, Cancer investigation.

A phase II study of the c-Met inhibitor tivantinib (tiv) in combination with FOLFOX for the treatment of patients (pts) with previously untreated metastatic adenocarcinoma of the distal esophagus, gastroesophageal (GE) junction, or stomach.

J. Bendell, C. Kurkjian, S. Pant, 2015 .

Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium

J. Hainsworth, D. Waterhouse, W. Penley, 2013, Cancer investigation.

Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non–small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2

J. Hainsworth, H. Burris, D. Spigel, 2018, Cancer.

A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors

Suzanne F. Jones, L. Hart, J. Bendell, 2015, Cancer investigation.

Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)

L. Sequist, A. Chiang, S. Gettinger, 2016 .

Preliminary Results From a Phase I/II Study of Fludarabine, Rituximab, and Lenalidomide In Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

I. Flinn, J. Hainsworth, H. Burris, 2010 .

Prolonged intermittent oral topotecan in patients with refractory and/or advanced malignancies

Suzanne F. Jones, J. Hainsworth, H. Burris, 2004 .

A Phase 2 Study of 5-Fluorouracil (5-FU), Ziv-Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients with Stage II/III Rectal Cancer

J. Bendell, A. Kennedy, D. Thompson, 2017, Cancer investigation.

Bevacizumab, erlotinib, and imatinib in the treatment of patients (pts) with advanced renal cell carcinoma (RCC): A Minnie Pearl Cancer Research Network phase I/II trial

J. Hainsworth, J. Sosman, L. Hart, 2005 .

Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.

J. Reeves, J. Hainsworth, H. Burris, 2010, Clinical lung cancer.

Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin.

J. Hainsworth, R. Hermann, H. Burris, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.

J. Hainsworth, H. Burris, D. Spigel, 2004, The Oncologist.

Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.

Suzanne F. Jones, J. Hainsworth, H. Burris, 2003, Oncology.

A Phase 2 Study of 5-Fluorouracil (5-FU), Ziv-Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients with Stage II/III Rectal Cancer

J. Bendell, A. Kennedy, B. Hemphill, 2017, Cancer investigation.

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.

J. Hainsworth, D. Spigel, F. Greco, 2009, The oncologist.